UCL Discovery
UCL home » Library Services » Electronic resources » UCL Discovery

Prevalence of MRI lesions in men responding to a GP-led invitation for a prostate health check: a prospective cohort study

Moore, Caroline M; Frangou, Elena; McCartan, Neil; Santaolalla, Aida; Kopcke, Douglas; Brembilla, Giorgio; Hadley, Joanna; ... Emberton, Mark; + view all (2023) Prevalence of MRI lesions in men responding to a GP-led invitation for a prostate health check: a prospective cohort study. BMJ Oncology , 2 (1) , Article e000057. 10.1136/bmjonc-2023-000057. Green open access

[thumbnail of e000057.full.pdf]
Preview
PDF
e000057.full.pdf - Published Version

Download (754kB) | Preview

Abstract

OBJECTIVE: In men with a raised prostate-specific antigen (PSA), MRI increases the detection of clinically significant cancer and reduces overdiagnosis, with fewer biopsies. MRI as a screening tool has not been assessed independently of PSA in a formal screening study. We report a systematic community-based assessment of the prevalence of prostate MRI lesions in an age-selected population. METHODS AND ANALYSIS: Men aged 50–75 were identified from participating general practice (GP) practices and randomly selected for invitation to a screening MRI and PSA. Men with a positive MRI or a raised PSA density (≥0.12 ng/mL2) were recommended for standard National Health Service (NHS) prostate cancer assessment. RESULTS: Eight GP practices sent invitations to 2096 men. 457 men (22%) responded and 303 completed both screening tests. Older white men were most likely to respond to the invitation, with black men having 20% of the acceptance rate of white men. One in six men (48/303 men, 16%) had a positive screening MRI, and an additional 1 in 20 men (16/303, 5%) had a raised PSA density alone. After NHS assessment, 29 men (9.6%) were diagnosed with clinically significant cancer and 3 men (1%) with clinically insignificant cancer. Two in three men with a positive MRI, and more than half of men with clinically significant disease had a PSA <3 ng/mL. CONCLUSIONS: Prostate MRI may have value in screening independently of PSA. These data will allow modelling of the use of MRI as a primary screening tool to inform larger prostate cancer screening studies. TRIAL REGISTRATION NUMBER: NCT04063566.

Type: Article
Title: Prevalence of MRI lesions in men responding to a GP-led invitation for a prostate health check: a prospective cohort study
Open access status: An open access version is available from UCL Discovery
DOI: 10.1136/bmjonc-2023-000057
Publisher version: http://dx.doi.org/10.1136/bmjonc-2023-000057
Language: English
Additional information: © Author(s) (or their employer[s]) 2023. Re-use permitted under CC BY. Published by BMJ (https://creativecommons.org/licenses/by/4.0/).
UCL classification: UCL
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Div of Surgery and Interventional Sci
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Div of Surgery and Interventional Sci > Department of Targeted Intervention
URI: https://discovery.ucl.ac.uk/id/eprint/10175851
Downloads since deposit
148Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item